These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 6596877

  • 1. [Laboratory and clinical study of ofloxacin in the treatment of bacterial prostatitis].
    Suzuki K, Tamai H, Naide Y, Ando K, Moriguchi R.
    Hinyokika Kiyo; 1984 Oct; 30(10):1505-18. PubMed ID: 6596877
    [Abstract] [Full Text] [Related]

  • 2. [Clinical study of cefclidin on bacterial prostatitis].
    Suzuki K, Horiba M, Naide Y, Hibi H.
    Hinyokika Kiyo; 1992 Apr; 38(4):507-10. PubMed ID: 1529828
    [Abstract] [Full Text] [Related]

  • 3. Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis.
    Naber KG, Roscher K, Botto H, Schaefer V.
    Int J Antimicrob Agents; 2008 Aug; 32(2):145-53. PubMed ID: 18571904
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Re-examination of the criteria for clinical evaluation on bacterial prostatitis--analysis of the data of the clinical study of temafloxacin].
    Arakawa S, Kamidono S, Hirose T, Kumamoto Y, Suzuki K, Ito Y, Ban Y, Kawada Y, Kumon H, Ohmori H.
    Hinyokika Kiyo; 1994 May; 40(5):455-66. PubMed ID: 8023771
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The effectiveness of a combination of trimethoprim plus rifampicin and local injection of antibiotics into the prostate in chronic bacterial prostatitis].
    Yamamoto M, Kanai S, Natsume H.
    Hinyokika Kiyo; 1985 Mar; 31(3):441-8. PubMed ID: 4025080
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Diffusion of ofloxacin (OFLX) into prostatic tissue in patients with benign prostatic hypertrophy].
    Uchibayashi T, Nagano K, Shoda R, Hisazumi H, Sawaki M, Yamaguchi K, Kawaguchi K, Komatsu K, Kobashi K, Koizumi H.
    Hinyokika Kiyo; 1990 Jun; 36(6):741-5. PubMed ID: 1700587
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Our experience with ofloxacin in the treatment of osteoarticular infections].
    Lopitaux R, Hermet R, Sirot J, Terver S, Levai JP.
    Pathol Biol (Paris); 1988 May; 36(5):557-61. PubMed ID: 3043357
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.